Rockefeller Capital Management
IMNM icon

Rockefeller Capital Management’s Immunome IMNM Stock Holding History

Rockefeller Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85 Hold
4
– – ﹤0.01% 4692
2026
Q1 		$87 Buy
+4
New +$89 ﹤0.01% 4640
2022
Q2 		– Sell
-20
Closed – – 4241
2022
Q1 		$0 Hold
20
– – ﹤0.01% 3966
2021
Q4 		$0 Hold
20
– – ﹤0.01% 3873
2021
Q3 		$0 Hold
20
– – ﹤0.01% 3753
2021
Q2 		$0 Hold
20
– – ﹤0.01% 3516
2021
Q1 		$0 Buy
+20
New +$497 ﹤0.01% 3315

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Rockefeller Capital Management's IMNM Position: Q2 2026 in Review

Rockefeller Capital Management held its Immunome (IMNM) position steady in Q2 2026 at 4 shares worth $85. The position accounts for ﹤0.01% of the portfolio, ranked #4692.

Rockefeller Capital Management first reported a position in IMNM in Q1 2021 and has held it in 7 quarters since. The position peaked at $87 in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Rockefeller Capital Management held 4 shares of Immunome worth $85 as of Q2 2026.
  • Rockefeller Capital Management left its Immunome share count unchanged in Q2 2026.
  • Immunome made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4692 holding.
  • Rockefeller Capital Management first reported a position in Immunome in Q1 2021 and has held it in 7 quarters since.
  • Rockefeller Capital Management's Immunome position peaked at $87 in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.